Home › Trial NCT00069901
Phase II CT-2103/Carboplatin in Ovarian Cancer
- Trial IDNCT00069901
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorCTI BioPharma
- Enrollment82
- Start date2003-02
- ConditionsOvarian Neoplasm
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.